MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Iptacopan

CAS No. : 1644670-37-0

MCE 站：Iptacopan

产品活性：Iptacopan (LNP023) 是一种首创的，有效的，具有口服活性的高选择性的 factor B 抑制剂，IC₅₀ 值为 10 nM。Iptacopan 直接可逆且高亲和力结合 factor B，K_D为 7.9 nM。Iptacopan 可靶向 C3 肾小球病的根本病因。

研究领域：Immunology/Inflammation

作用靶点：Complement System

In Vitro: Iptacopan (LNP023) demonstrates potent inhibition of alternative complement pathway (AP)-induced membrane attack complex (MAC) formation in 50% human serum (IC₅₀ value of 130 nM).
Iptacopan (LNP023) exhibits excellent selectivity over other proteases affording IC₅₀ values of >30 μM across a panel of 41 human proteases, including the AP protein factor D (>100 μM).

In Vivo: Iptacopan (LNP023; 20-180 mg/kg; oral administration) prevents KRN (150 μL)-induced arthritis in mice and is effective upon prophylactic and therapeutic dosing in an experimental model of membranous nephropathy in rats.
LNP023 exhibits moderate half-lives (T_1/2; Wistar Han rats 3.4 h, beagle dogs 5.5 h) and C_max (Wistar Han rats 410 nM, beagle dogs 2200 nM) following oral administration (rat 30 and, dog 10 mg/kg).
Iptacopan exhibits terminal elimination half-lives (T_1/2; Wistar Han rats 7 h, beagle dogs 5.6 h) due to high plasma clearance (8, and 2 mL/min/kg respectively combined with large volumes of distribution (2.3, and 0.6 L/kg respectively) following intravenous administration (rat 1.0 and, dog 0.1 mg/kg).

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Clinical Compound Library  |  Drug Repurposing Compound Library  |  Dexamethasone  |  Cyclosporin A  |  SB290157 trifluoroacetate  |  EG00229  |  PMX-53  |  PMX 205 Trifluoroacetate  |  Leukadherin-1  |  EG01377 dihydrochloride  |  BCX 1470 methanesulfonate  |  W-54011  |  Compstatin  |  TLQP-21 TFA  |  C3a (70-77) TFA  |  FD-IN-1  |  NDT 9513727  |  Compstatin control peptide  |  POT-4

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。